pentobarbital will lessen the level or effect of etravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lessen the extent or influence of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will lessen the extent or impact of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the level or result of alprazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the extent or result of nicardipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lower the level or effect of apremilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with potent CYP inducers ends in a substantial lessen of systemic publicity of apremilast, which can result in lack of efficacy
Monoamine oxidase inhibitors (MAOI) may possibly inhibit barbiturate metabolism and lengthen barbiturate effects; observe carefully
pentobarbital will decrease the level or impact of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will lower the extent or effect of conjugated estrogens, vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will decrease the level or outcome of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
Contraindicated (1)pentobarbital will decrease the extent or result of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
Comment: Barbiturates may increase adverse effects, such as respiratory melancholy, made by poisonous doses of TCAs. With therapeutic doses of TCAs, barbiturates increase metabolism and reduce blood concentrations of TCAs.
pentobarbital will lower the level or impact of rolapitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer read more clear of or Use Alternate Drug. Lengthy-time period coadministration of robust CYP3A4 inducers with rolapitant may perhaps drastically minimize rolapitant efficacy.
pentobarbital will minimize the extent or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Mysterious.